• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔黏膜下纤维化中PTEN免疫表达的评估:在发病机制和恶性转化中的作用

Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.

作者信息

Angadi Punnya V, Krishnapillai Rekha

机构信息

Department of Oral Pathology and Microbiology, KLEVK Institute of Dental Sciences and Hospital, Belgaum, 590010, Karnataka, India.

出版信息

Head Neck Pathol. 2012 Sep;6(3):314-21. doi: 10.1007/s12105-012-0341-z. Epub 2012 Mar 6.

DOI:10.1007/s12105-012-0341-z
PMID:22392409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3422583/
Abstract

Oral submucous fibrosis (OSMF) is a chronic debilitating disease and a premalignant condition of the oral cavity characterized by generalized submucosal fibrosis. Despite its precancerous nature, the molecular biology regarding its malignant potential has not been extensively studied. PTEN, a known tumor suppressor gene is mutated in a majority of human cancers and has also been implicated in several fibrotic disorders. The present study aims to evaluate the expression of PTEN in OSMF and oral squamous cell carcinoma (OSCC) and correlate it with the pathogenesis and malignant transformation of OSMF. 60 cases total of OSMF (30) and OSCC (30) were subjected to immunohistochemistry using PTEN antibody. Ten normal oral mucosa (NOM) specimens were also stained as controls. There was progressive loss of PTEN expression from normal mucosa to OSMF and OSCC (p ≤ 0.001). Significant differences were observed for PTEN expression between NOM and OSMF, OSMF and OSCC as well as NOM and OSCC. Though a progressive loss of PTEN was noticed between early OSMF and advanced OSMF, the variation did not reach statistical significance (p ≥ 0.001). Data suggest that there is a significant loss of PTEN expression in OSMF as compared to normal oral mucosa and that this trend increased from OSMF to OSCC. Thus, alteration of PTEN is likely an important molecular event in OSMF pathogenesis and oral carcinogenesis.

摘要

口腔黏膜下纤维化(OSMF)是一种慢性致残性疾病,是口腔的一种癌前病变,其特征为广泛性黏膜下纤维化。尽管它具有癌前性质,但其恶性潜能的分子生物学尚未得到广泛研究。PTEN是一种已知的肿瘤抑制基因,在大多数人类癌症中发生突变,并且也与几种纤维化疾病有关。本研究旨在评估PTEN在OSMF和口腔鳞状细胞癌(OSCC)中的表达,并将其与OSMF的发病机制和恶性转化相关联。总共60例OSMF(30例)和OSCC(30例)病例使用PTEN抗体进行免疫组织化学检测。另外10例正常口腔黏膜(NOM)标本也进行染色作为对照。从正常黏膜到OSMF和OSCC,PTEN表达逐渐丧失(p≤0.001)。在NOM与OSMF、OSMF与OSCC以及NOM与OSCC之间观察到PTEN表达存在显著差异。尽管在早期OSMF和晚期OSMF之间注意到PTEN有逐渐丧失的情况,但这种差异未达到统计学意义(p≥0.001)。数据表明,与正常口腔黏膜相比,OSMF中PTEN表达显著丧失,并且这种趋势从OSMF到OSCC有所增加。因此,PTEN的改变可能是OSMF发病机制和口腔癌发生中的一个重要分子事件。

相似文献

1
Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.口腔黏膜下纤维化中PTEN免疫表达的评估:在发病机制和恶性转化中的作用
Head Neck Pathol. 2012 Sep;6(3):314-21. doi: 10.1007/s12105-012-0341-z. Epub 2012 Mar 6.
2
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.端粒酶逆转录酶在口腔黏膜下纤维性变和口腔鳞状细胞癌中的表达——免疫组织化学分析。
Pathol Oncol Res. 2020 Jul;26(3):1573-1582. doi: 10.1007/s12253-019-00700-6. Epub 2019 Sep 5.
3
Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.p21和Bcl-2在白斑、口腔黏膜下纤维化及口腔鳞状细胞癌中的免疫组织化学研究
J Exp Ther Oncol. 2016 Nov;11(4):285-292.
4
Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.c-Jun在正常黏膜、口腔黏膜下纤维化、上皮发育异常及口腔鳞状细胞癌中的免疫定位:一项比较研究。
J Cancer Res Ther. 2018 Oct-Dec;14(6):1180-1183. doi: 10.4103/jcrt.JCRT_324_16.
5
Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.骨桥蛋白:侵袭性口腔鳞状细胞癌的标志物,但不是潜在恶性上皮异型增生的标志物。
Ann Diagn Pathol. 2013 Oct;17(5):421-4. doi: 10.1016/j.anndiagpath.2013.03.005. Epub 2013 May 24.
6
Expression of Ki67 Biomarker in Oral Submucous Fibrosis with Clinico-Pathological Correlations: A Prospective Study.Ki67 生物标志物在口腔黏膜下纤维性变中的表达及其与临床病理相关性的前瞻性研究。
Asian Pac J Cancer Prev. 2022 Jan 1;23(1):253-259. doi: 10.31557/APJCP.2022.23.1.253.
7
Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.成纤维细胞生长因子(FGF - 2)及其受体FGFR - 2和FGFR - 3可能是潜在恶性口腔病变向口腔鳞状细胞癌恶性转化的假定生物标志物。
PLoS One. 2015 Oct 14;10(10):e0138801. doi: 10.1371/journal.pone.0138801. eCollection 2015.
8
Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.口腔黏膜下纤维性变背景下的口腔鳞状细胞癌是一种具有独特临床病理特征的疾病,其预后较好。
J Oral Pathol Med. 2017 Jul;46(6):448-453. doi: 10.1111/jop.12553. Epub 2017 Feb 28.
9
Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.bcl-2癌蛋白在口腔潜在恶性疾病和鳞状细胞癌中的作用:一项免疫组织化学研究
Indian J Dent Res. 2011 Jul-Aug;22(4):520-5. doi: 10.4103/0970-9290.90286.
10
Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.p53和p63在口腔鳞状细胞癌、口腔白斑及口腔黏膜下纤维化中的免疫组化检测
J Investig Clin Dent. 2014 Aug;5(3):214-9. doi: 10.1111/jicd.12038. Epub 2013 Jun 18.

引用本文的文献

1
Molecular Genomics of Oral Submucous Fibrosis: A Narrative Review.口腔黏膜下纤维化的分子基因组学:一项叙述性综述。
Genes (Basel). 2025 May 22;16(6):612. doi: 10.3390/genes16060612.
2
Mechanisms and markers of malignant transformation of oral submucous fibrosis.口腔黏膜下纤维化恶性转化的机制与标志物
Heliyon. 2023 Dec 7;10(1):e23314. doi: 10.1016/j.heliyon.2023.e23314. eCollection 2024 Jan 15.
3
Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma-A Systematic Review and Meta-Analysis.口腔黏膜下纤维性变和口腔黏膜下纤维性变转化为口腔鳞状细胞癌的免疫组织化学标志物比较:系统评价和荟萃分析。
Int J Mol Sci. 2023 Jul 21;24(14):11771. doi: 10.3390/ijms241411771.
4
Expression sites of immunohistochemistry markers in oral diseases - A scoping review.口腔疾病中免疫组织化学标志物的表达部位——一项范围综述
J Oral Maxillofac Pathol. 2022 Oct-Dec;26(4):524-533. doi: 10.4103/jomfp.jomfp_364_22. Epub 2022 Dec 22.
5
Clinical Perspectives of Non-Coding RNA in Oral Inflammatory Diseases and Neuropathic Pain: A Narrative Review.非编码 RNA 在口腔炎症性疾病和神经病理性疼痛中的临床研究进展:综述
Int J Mol Sci. 2022 Jul 27;23(15):8278. doi: 10.3390/ijms23158278.
6
Long Non-Coding RNAs in Oral Submucous Fibrosis: Their Functional Mechanisms and Recent Research Progress.口腔黏膜下纤维化中的长链非编码RNA:其功能机制及最新研究进展
J Inflamm Res. 2021 Nov 3;14:5787-5800. doi: 10.2147/JIR.S337014. eCollection 2021.
7
Evaluation of immunohistochemical expression of epithelial- mesenchymal transition markers E-cadherin, Twist and Snail in oral submucous fibrosis and their possible association with malignant transformation.口腔黏膜下纤维化中上皮-间质转化标志物E-钙黏蛋白、Twist和Snail的免疫组化表达评估及其与恶性转化的可能关联。
J Oral Maxillofac Pathol. 2021 Jan-Apr;25(1):97-104. doi: 10.4103/jomfp.jomfp_454_20. Epub 2021 May 14.
8
Orofacial Manifestations Assisting the Diagnosis of Cowden Syndrome in a Middle-Aged Patient: Case Report and Literature Overview.口面部表现辅助诊断中年患者的考登综合征:病例报告与文献综述
Head Neck Pathol. 2022 Mar;16(1):304-313. doi: 10.1007/s12105-021-01345-1. Epub 2021 Jun 9.
9
PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis.PTEN和α - 平滑肌肌动蛋白在口腔黏膜下纤维化及伴发口腔黏膜下纤维化的口腔鳞状细胞癌中的表达及诊断作用
J Oral Maxillofac Res. 2021 Mar 31;12(1):e3. doi: 10.5037/jomr.2021.12103. eCollection 2021 Jan-Mar.
10
Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?PIK3CA和PTEN生物标志物在口腔鳞状细胞癌预后中起作用吗?
Life (Basel). 2020 Dec 3;10(12):325. doi: 10.3390/life10120325.

本文引用的文献

1
Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity.评估口腔黏膜下纤维性变中的肌纤维母细胞:与疾病严重程度的相关性。
J Oral Pathol Med. 2011 Mar;40(3):208-13. doi: 10.1111/j.1600-0714.2010.00995.x. Epub 2010 Dec 28.
2
Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.源于槟榔的生物碱上调角质形成细胞 αvβ6 整联蛋白表达并促进口腔黏膜下纤维性变。
J Pathol. 2011 Feb;223(3):366-77. doi: 10.1002/path.2786. Epub 2010 Oct 25.
3
Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression.通过评估 p63、E-钙黏蛋白和 CD105 的表达来评估口腔黏膜下纤维性变的恶性潜能。
J Clin Pathol. 2010 Oct;63(10):894-9. doi: 10.1136/jcp.2010.078964.
4
Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levels.二氢神经鞘氨醇-1-磷酸通过使磷酸酶和张力蛋白同源物水平正常化,对硬皮病成纤维细胞具有强大的抗纤维化作用。
Arthritis Rheum. 2010 Jul;62(7):2117-26. doi: 10.1002/art.27463.
5
PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis.在胆管狭窄诱导的肝纤维化大鼠的肝组织中,PTEN表达下调。
APMIS. 2009 Sep;117(9):681-91. doi: 10.1111/j.1600-0463.2009.02515.x.
6
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.转化生长因子-β通过靶向磷酸酶和张力蛋白同源物(PTEN)的微小RNA依赖性放大回路激活Akt激酶。
Nat Cell Biol. 2009 Jul;11(7):881-9. doi: 10.1038/ncb1897. Epub 2009 Jun 21.
7
Arecoline and oral keratinocytes may affect the collagen metabolism of fibroblasts.槟榔碱和口腔角质形成细胞可能会影响成纤维细胞的胶原代谢。
J Oral Pathol Med. 2009 May;38(5):422-6. doi: 10.1111/j.1600-0714.2009.00758.x. Epub 2009 Mar 23.
8
Oral squamous cell carcinoma overview.口腔鳞状细胞癌概述
Oral Oncol. 2009 Apr-May;45(4-5):301-8. doi: 10.1016/j.oraloncology.2009.01.004. Epub 2009 Feb 26.
9
Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles.10号染色体缺失的磷酸酶和张力蛋白同源物:伸展其“触角”
Int J Biochem Cell Biol. 2009 Apr;41(4):757-61. doi: 10.1016/j.biocel.2008.09.022. Epub 2008 Oct 2.
10
Global epidemiology of oral and oropharyngeal cancer.口腔和口咽癌的全球流行病学。
Oral Oncol. 2009 Apr-May;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002. Epub 2008 Sep 18.